Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-24-132925

Chief Scientific Officer sold 22,081 shares at $4.56 ($100,592)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barone Francesca Chief Scientific Officer 2024-11-29 Sale −22,081 $4.56 $100,592 137,880 D
Open-market sales · 22,081 sh · avg $4.56 · $100,592
Loading xslF345X05/ownership.xml…